First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT

First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT

Saved in:

Bibliographic Details
Main Authors:	Annie Bjäreback, Olof Jonmarker, Antonios Tzortzakakis, Emma Jussing, Chunde Li, Renske Altena, Cecilia Hindorf, Anna Orlova, Rimma Axelsson, Thuy A. Tran
Format:	Article
Language:	English
Published:	SpringerOpen 2025-02-01
Series:	EJNMMI Research
Online Access:	https://doi.org/10.1186/s13550-025-01204-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A preclinical study on the influence of linkers in [68Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression
by: Esther Olaniran Håkansson, et al.
Published: (2025-08-01)

68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study
by: Yilin Li, et al.
Published: (2025-01-01)

Bidirectional dynamic frame prediction network for total-body [68Ga]Ga-PSMA-11 and [68Ga]Ga-FAPI-04 PET images
by: Qianyi Yang, et al.
Published: (2024-11-01)

Initial clinical experience with 68Ga-DOTA-NOC prepared using 68Ga from nanoceria-polyacrylonitrile composite sorbent-based 68Ge/68Ga generator and freeze-dried DOTA-NOC kits
by: Piyush Chandra, et al.
Published: (2017-04-01)

Towards a General Method for Using Cyclotron-Produced Ga68 to Manufacture Clinical and Research Ga68 Tracers
by: Ivan E. Wang, et al.
Published: (2024-11-01)

Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients
by: Camila Gadens Zamboni, et al.
Published: (2024-11-01)

EVALUATION OF 68Ge/68Ga GENERATOR PRE-ELUTION EFFICIENCY ON METALLIC IMPURITIES IN THE COMPOSITION OF 68GaPSMA-11 RADIOPHARMACEUTICAL IN NUCLEAR MEDICINE PET CHEMISTRY
by: Ayşe Uğur, et al.
Published: (2021-09-01)

Impact of hyperglycemia and antidiabetic medication on pancreatic uptake on [68Ga]Ga-DOTATOC PET/CT
by: Sophie Carina Kunte, et al.
Published: (2025-05-01)

<sup>68</sup>Ga Extemporaneous Preparations in Radiopharmacy
by: Marzia Rizzello, et al.
Published: (2025-06-01)

Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [18F]MeTz-PEG2-RM26 for positron emission tomography
by: Panagiotis Kanellopoulos, et al.
Published: (2025-03-01)

A comparison of routine [68Ga]Ga-PSMA-11 preparation using Locametz and Illuccix kits
by: Ivan E. Wang, et al.
Published: (2024-12-01)

Optimizing Standardization Systems and Standardizing Clinical Practice: Interpretation of Quality Standards for Medical 68Ge/68Ga Generators and 68Ga Radiopharmaceuticals and Quality Standards for Medical 177Lu and Its Radiopharmaceuticals
by: LAI Yuxin, et al.
Published: (2025-07-01)

The influence of generator eluate in radiolabeling PSMA-11 kit with 68Ga
by: Bianca Franchesqueti Vivaldini, et al.
Published: (2021-04-01)

Synthesis and Characterization of Star-Shaped Block Copolymer sPCL-b-PEG-GA
by: Yi Zhang, et al.
Published: (2014-01-01)

An Innovative Approach with [<sup>68</sup>Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings
by: Gozde Mutevelizade, et al.
Published: (2025-07-01)

Impact of patient size on image quality of OSEM3D and BSREM reconstructions in [68Ga]Ga-DOTA-TATE PET/MR
by: Christina P. W. Cox, et al.
Published: (2025-07-01)

Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP)
by: Rebecca Rizzo, et al.
Published: (2025-08-01)

Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI
by: Clemens P. Spielvogel, et al.
Published: (2024-12-01)

Noninvasive Monitoring of Programmed Death-Ligand 2 Expression with Positron Emission Tomography using 68Ga-labeled Peptide Antagonist in Preclinical and Exploratory Human Studies
by: Yajie Zhao, et al.
Published: (2024-01-01)

Imply on diagnosis and early prognosis of preoperative [68Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin
by: K. Pełka, et al.
Published: (2025-01-01)

Comparison of inter- and intraobserver agreement between [18F]AlF-NOTA-octreotide and [68Ga]Ga-DOTA-SSA PET/CT
by: Hannes Leupe, et al.
Published: (2025-05-01)

Perfomance analysis of a small animal PET scanner using 68Ga Isotope
by: Victória Garcia Moreira, et al.
Published: (2025-06-01)

Spatial Resolution of a small animal PET scanner using 68Ga isotope
by: Victoria M. Garcia, et al.
Published: (2024-04-01)

68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
by: Ronald Walker, et al.
Published: (2017-01-01)

68Ga-labeled fluorinated benzamide derivatives for positron emission tomography imaging of melanoma.
by: Chaewon Lee, et al.
Published: (2025-01-01)

68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
by: Joe-Elie Salem, et al.
Published: (2021-10-01)

Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma
by: Qingqing Pan, et al.
Published: (2025-06-01)

Publisher Correction: On the automated radiosynthesis of pharmaceutical grade [68Ga]Ga-Pentixafor, its pre-clinical evaluation, clinical application and radiation dosimetry aspects
by: Sreeja Raj Menon, et al.
Published: (2025-04-01)

Optimization of radiochemical purity assessment for [68Ga]Ga-EDOTREOTIDE (Somakit-TOC®): a shortened r-TLC method for improved PET radiopharmaceutical workflow
by: Arnaud Deschavannes, et al.
Published: (2025-05-01)

Using the PET/CT radiotracer [68Ga]Ga-DOTA-mDesmo to target V1b receptors and localize corticotropinoma in Cushing’s disease
by: Somit Pandey, et al.
Published: (2025-08-01)

Comparing the Diagnostic Performance of [18F]PSMA‐1007 With [68Ga]Ga‐PSMA‐11 in PET/CT Imaging and Staging of Recurrent Prostate Cancer
by: Negar Abdi, et al.
Published: (2025-03-01)

[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial
by: Lucia Zanoni, et al.
Published: (2024-11-01)

68Ga-radiolabeled fluorescent dye for potential non-invasive multimodal imaging of subarachnoid hemorrhage
by: Jona Wilhelm Gerhards, et al.
Published: (2025-07-01)

Sum-peak method with two NaI(Tl) crystals: 68(Ge+Ga) standardization
by: Estela Maria Oliveira, et al.
Published: (2019-10-01)

68Ga-DOTATATE Uptake in COVID-19 Pneumonia: A Non-Neoplastic False Positive
by: Joshua P. Weissman, et al.
Published: (2022-06-01)

THE IMPACT OF 68GA-PSMA PET/CT ON THERAPY MANAGEMENT OF HIGH RISK PROSTATE CANCER
by: Duygu Has Şimşek, et al.
Published: (2021-01-01)

Preclinical Evaluation of <sup>68</sup>Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis
by: O. E. Klementyeva, et al.
Published: (2020-08-01)

68Ga-Labeled Peptide for Noninvasive Quantifying Tumor Exposure of PD-L1 Therapeutics
by: Hui Nie, et al.
Published: (2025-03-01)

Indications and Results for Ga-68 PSMA PET/CT in Patients with Biochemical Relapse of Prostate Cancer
by: Ivan Rogić, et al.
Published: (2024-01-01)

Numerical Analysis of AlGaAs/InGaAs/GaAs pHEMT
by: A. V. Sapozhnikov, et al.
Published: (2025-07-01)